Report Detail

Pharma & Healthcare Global Non-opioid Topical Pain Relief Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4743878
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Non-opioid Topical Pain Relief market size was valued at US$ 1043 million in 2025 and is forecast to a readjusted size of US$ 1378 million by 2032 with a CAGR of 4.1% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Non-opioid Topical Pain Relief market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-opioid Topical Pain Relief market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-opioid Topical Pain Relief market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-opioid Topical Pain Relief market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-opioid Topical Pain Relief market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-opioid Topical Pain Relief
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-opioid Topical Pain Relief market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, GlaxoSmithKline, Pfizer, Hisamitsu, Mylan, Reckitt Benckiser Group, Sanofi, Teva Pharmaceutical, Sun Pharmaceutical Industries, Lingrui Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-opioid Topical Pain Relief market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prescription Pain Relief
Over-The-Counter Pain Relief
Market segment by Application
Pharmacy
Clinic
Hospital
Others
Major players covered
Johnson and Johnson
GlaxoSmithKline
Pfizer
Hisamitsu
Mylan
Reckitt Benckiser Group
Sanofi
Teva Pharmaceutical
Sun Pharmaceutical Industries
Lingrui Pharmaceutical
Tibet Cheezheng Tibetan Medicine
China Resources Sanjiu Medical & Pharmaceutical
Topical BioMedics
AdvaCare Pharma
Abacus Health Products
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-opioid Topical Pain Relief product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-opioid Topical Pain Relief, with price, sales quantity, revenue, and global market share of Non-opioid Topical Pain Relief from 2021 to 2026.
Chapter 3, the Non-opioid Topical Pain Relief competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-opioid Topical Pain Relief breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-opioid Topical Pain Relief market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-opioid Topical Pain Relief.
Chapter 14 and 15, to describe Non-opioid Topical Pain Relief sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-opioid Topical Pain Relief Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Prescription Pain Relief
    • 1.3.3 Over-The-Counter Pain Relief
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Non-opioid Topical Pain Relief Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmacy
    • 1.4.3 Clinic
    • 1.4.4 Hospital
    • 1.4.5 Others
  • 1.5 Global Non-opioid Topical Pain Relief Market Size & Forecast
    • 1.5.1 Global Non-opioid Topical Pain Relief Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Non-opioid Topical Pain Relief Sales Quantity (2021-2032)
    • 1.5.3 Global Non-opioid Topical Pain Relief Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Johnson and Johnson
    • 2.1.1 Johnson and Johnson Details
    • 2.1.2 Johnson and Johnson Major Business
    • 2.1.3 Johnson and Johnson Non-opioid Topical Pain Relief Product and Services
    • 2.1.4 Johnson and Johnson Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Johnson and Johnson Recent Developments/Updates
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Non-opioid Topical Pain Relief Product and Services
    • 2.2.4 GlaxoSmithKline Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GlaxoSmithKline Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Non-opioid Topical Pain Relief Product and Services
    • 2.3.4 Pfizer Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Hisamitsu
    • 2.4.1 Hisamitsu Details
    • 2.4.2 Hisamitsu Major Business
    • 2.4.3 Hisamitsu Non-opioid Topical Pain Relief Product and Services
    • 2.4.4 Hisamitsu Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Hisamitsu Recent Developments/Updates
  • 2.5 Mylan
    • 2.5.1 Mylan Details
    • 2.5.2 Mylan Major Business
    • 2.5.3 Mylan Non-opioid Topical Pain Relief Product and Services
    • 2.5.4 Mylan Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mylan Recent Developments/Updates
  • 2.6 Reckitt Benckiser Group
    • 2.6.1 Reckitt Benckiser Group Details
    • 2.6.2 Reckitt Benckiser Group Major Business
    • 2.6.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product and Services
    • 2.6.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Reckitt Benckiser Group Recent Developments/Updates
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Non-opioid Topical Pain Relief Product and Services
    • 2.7.4 Sanofi Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sanofi Recent Developments/Updates
  • 2.8 Teva Pharmaceutical
    • 2.8.1 Teva Pharmaceutical Details
    • 2.8.2 Teva Pharmaceutical Major Business
    • 2.8.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Product and Services
    • 2.8.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.9 Sun Pharmaceutical Industries
    • 2.9.1 Sun Pharmaceutical Industries Details
    • 2.9.2 Sun Pharmaceutical Industries Major Business
    • 2.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product and Services
    • 2.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
  • 2.10 Lingrui Pharmaceutical
    • 2.10.1 Lingrui Pharmaceutical Details
    • 2.10.2 Lingrui Pharmaceutical Major Business
    • 2.10.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product and Services
    • 2.10.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lingrui Pharmaceutical Recent Developments/Updates
  • 2.11 Tibet Cheezheng Tibetan Medicine
    • 2.11.1 Tibet Cheezheng Tibetan Medicine Details
    • 2.11.2 Tibet Cheezheng Tibetan Medicine Major Business
    • 2.11.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product and Services
    • 2.11.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Tibet Cheezheng Tibetan Medicine Recent Developments/Updates
  • 2.12 China Resources Sanjiu Medical & Pharmaceutical
    • 2.12.1 China Resources Sanjiu Medical & Pharmaceutical Details
    • 2.12.2 China Resources Sanjiu Medical & Pharmaceutical Major Business
    • 2.12.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product and Services
    • 2.12.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
  • 2.13 Topical BioMedics
    • 2.13.1 Topical BioMedics Details
    • 2.13.2 Topical BioMedics Major Business
    • 2.13.3 Topical BioMedics Non-opioid Topical Pain Relief Product and Services
    • 2.13.4 Topical BioMedics Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Topical BioMedics Recent Developments/Updates
  • 2.14 AdvaCare Pharma
    • 2.14.1 AdvaCare Pharma Details
    • 2.14.2 AdvaCare Pharma Major Business
    • 2.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Product and Services
    • 2.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AdvaCare Pharma Recent Developments/Updates
  • 2.15 Abacus Health Products
    • 2.15.1 Abacus Health Products Details
    • 2.15.2 Abacus Health Products Major Business
    • 2.15.3 Abacus Health Products Non-opioid Topical Pain Relief Product and Services
    • 2.15.4 Abacus Health Products Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Abacus Health Products Recent Developments/Updates

3 Competitive Environment: Non-opioid Topical Pain Relief by Manufacturer

  • 3.1 Global Non-opioid Topical Pain Relief Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Non-opioid Topical Pain Relief Revenue by Manufacturer (2021-2026)
  • 3.3 Global Non-opioid Topical Pain Relief Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Non-opioid Topical Pain Relief by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Non-opioid Topical Pain Relief Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Non-opioid Topical Pain Relief Manufacturer Market Share in 2025
  • 3.5 Non-opioid Topical Pain Relief Market: Overall Company Footprint Analysis
    • 3.5.1 Non-opioid Topical Pain Relief Market: Region Footprint
    • 3.5.2 Non-opioid Topical Pain Relief Market: Company Product Type Footprint
    • 3.5.3 Non-opioid Topical Pain Relief Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-opioid Topical Pain Relief Market Size by Region
    • 4.1.1 Global Non-opioid Topical Pain Relief Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Non-opioid Topical Pain Relief Consumption Value by Region (2021-2032)
    • 4.1.3 Global Non-opioid Topical Pain Relief Average Price by Region (2021-2032)
  • 4.2 North America Non-opioid Topical Pain Relief Consumption Value (2021-2032)
  • 4.3 Europe Non-opioid Topical Pain Relief Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Non-opioid Topical Pain Relief Consumption Value (2021-2032)
  • 4.5 South America Non-opioid Topical Pain Relief Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Non-opioid Topical Pain Relief Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 5.2 Global Non-opioid Topical Pain Relief Consumption Value by Type (2021-2032)
  • 5.3 Global Non-opioid Topical Pain Relief Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 6.2 Global Non-opioid Topical Pain Relief Consumption Value by Application (2021-2032)
  • 6.3 Global Non-opioid Topical Pain Relief Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 7.2 North America Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 7.3 North America Non-opioid Topical Pain Relief Market Size by Country
    • 7.3.1 North America Non-opioid Topical Pain Relief Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Non-opioid Topical Pain Relief Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 8.2 Europe Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 8.3 Europe Non-opioid Topical Pain Relief Market Size by Country
    • 8.3.1 Europe Non-opioid Topical Pain Relief Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Non-opioid Topical Pain Relief Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Non-opioid Topical Pain Relief Market Size by Region
    • 9.3.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Non-opioid Topical Pain Relief Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 10.2 South America Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 10.3 South America Non-opioid Topical Pain Relief Market Size by Country
    • 10.3.1 South America Non-opioid Topical Pain Relief Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Non-opioid Topical Pain Relief Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Non-opioid Topical Pain Relief Market Size by Country
    • 11.3.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Non-opioid Topical Pain Relief Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Non-opioid Topical Pain Relief Market Drivers
  • 12.2 Non-opioid Topical Pain Relief Market Restraints
  • 12.3 Non-opioid Topical Pain Relief Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-opioid Topical Pain Relief and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-opioid Topical Pain Relief
  • 13.3 Non-opioid Topical Pain Relief Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-opioid Topical Pain Relief Typical Distributors
  • 14.3 Non-opioid Topical Pain Relief Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Non-opioid Topical Pain Relief. Industry analysis & Market Report on Non-opioid Topical Pain Relief is a syndicated market report, published as Global Non-opioid Topical Pain Relief Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-opioid Topical Pain Relief market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report